在Vogt-Koyanagi-Harada疾病患者的光学一致性断层扫描和视觉结果的基线黄斑形态特征之间的关联
Miel Sundararajan1,2,3, Sivakumar R Rathinam4, Radhika Thundikandy5
1Department of Ophthalmology, University of Washington, Seattle, Washington, USA.
Ocular immunology and inflammation
|August 27, 2024
概括
在Vogt-Koyanagi-Harada (VKH) 疾病中的光谱域光学连贯性断层扫描 (SD-OCT) 特性没有预测视觉结果. 然而,有效的免疫抑制导致大多数患者的视力敏度很好.
科学领域:
- 眼科医生 眼科 眼科
- 免疫抑制疗法是一种免疫抑制疗法.
- 医学成像医学成像
背景情况:
- 沃格特-科亚纳吉-哈拉达 (VKH) 疾病的特征是胸膜厚和血清性视网膜脱落.
- 谱域光学连贯性断层扫描 (SD-OCT) 提供了这些眼部表现的详细成像.
- 评估SD-OCT功能来预测VKH视觉结果对于治疗规划至关重要.
研究的目的:
- 评估在呈现时特定的SD-OCT发现与VKH疾病中的视觉结果之间的关联.
- 为了比较甲索特雷克萨特与mycophenolate mofetil在治疗VKH相关性脑膜炎方面的疗效.
- 确定SD-OCT的定性和定量特征是否预测VKH患者的视力敏度.
主要方法:
- 进行了FAST试验 (NCT01829295) 的探索性亚分析.
- 从158名VKH参与者的SD-OCT图像中分析了细菌脱落,RPE折叠和ILM波动.
- 修改后的RPE波浪指数被计算为胆道的定量度量.
主要成果:
- 在基线时,在23.5%的眼睛中存在细菌脱落,在22.8%的眼睛中存在RPE折叠,在35.2%的眼睛中存在ILM波动.
- 一个更高的修改后的RPE波动指数与较差的基线视力敏度相关.
- 呈现时没有SD-OCT特征与6个月终点的视力敏度相关;对于大多数患者来说,最终的视力敏度很好 (0.1-0.2 logMAR).
结论:
- 虽然SD-OCT在呈现时揭示了VKH的各种病理,但这些特征并不能预测长期的视觉结果.
- 有效的免疫抑制用甲甲酸或mycophenolate mofetil与VKH疾病的优良视觉结果有关.
- 及时和适当的免疫抑制疗法是实现VKH患者良好的视觉预后的关键.
更多相关视频
10:14Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
3.1K
05:14Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
Published on: August 11, 2023
1.0K
相关概念视频
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...